CAPITAL DRUG DEVELOPMENT LTD

Active
Company number 12540893Private limited companyIncorporated 2020

Key figures

£493,775+253.6%
Net assets 2025
-500 k-250 k0250 k500 k20212025

† CAPITAL DRUG DEVELOPMENT LTD filed these accounts on paper, so Companies House publishes them only as a scanned image. The figures for the years marked † were read automatically from the scan and kept only where the statements add up (for example net assets equal total equity), but a reading error is still possible — check the original accounts at Companies House.

CAPITAL DRUG DEVELOPMENT LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025

Sector comparison

SIC 72190

Where the company stands among the 5,632 active companies whose first SIC code is 72190 (Other research and experimental development on natural sciences and engineering).

Net assets£493,775
Higher than 82% · median £10,692
Total assets£11,275,661
Higher than 94% · median £64,502
Company age6.6 years
Younger than 54% · median 7.5 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 5,632. The line on each bar marks the median.

Summary: CAPITAL DRUG DEVELOPMENT LTD

What kind of company is it?

CAPITAL DRUG DEVELOPMENT LTD is a private limited company registered with Companies House under company number 12540893. It was incorporated on 31 Mar 2020. Its status is active. The registered office is in Cardiff (CF3). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files audit-exempt subsidiary. Loss for the year was £6,457. Net assets were £493,775, up 253.6% on the previous year. Total assets were £11,275,661 and total liabilities £10,779,538. Figures are available for 2 financial years (2021–2025).

How does it compare with similar companies?

Compared with 5,632 active companies whose first SIC code is 72190: By net assets it ranks higher than 82% of them (median £10,692). By total assets it ranks higher than 94% of them (median £64,502). It is younger than 54% of them (median age 7.5 years).

Who runs and controls the company?

One person with significant control is registered. 1 of 2 registered charges are outstanding.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 18 Nov 2026.

Filed accounts2021–2025
20212025 †
Profit for the year—-6,457
Cash at bank and in hand62,863—
Total assets963,60011,275,661
Total liabilities1,285,16210,779,538
Net assets / total equity-321,562493,775
Average number of employees4—

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

History

10 events
  1. Financial year 2025 endedAccounts: net assets £493.8k
  2. Catsci Holdings Limited registered as a person with significant control
  3. Dr Ed Robert Turp ceased to be a person with significant control
  4. Ross Thomas Burn ceased to be a person with significant control
  5. Dr Simon Nicholas George Tyler ceased to be a person with significant control
  6. Financial year 2021 endedAccounts: net assets −£321.6k, 4 employees
  7. Dr Ed Robert Turp registered as a person with significant control
  8. Ross Thomas Burn registered as a person with significant control
Earlier events (2)
  1. Dr Simon Nicholas George Tyler registered as a person with significant control
  2. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.